(18 Mar 2025, 12:53)

Sun Pharma gains as arm acquires Antibe Therapeutics for $4.5 Million

Sun Pharmaceutical Industries rose 1.14% to Rs 1,725.55 after its subsidiary, TARO Pharmaceuticals Inc., completed the 100% acquisition of Antibe Therapeutics Inc. of Canada for a total consideration of $4.5 million.

Sun Pharmaceuticals Industries is a leading global pharmaceutical company with a specialty and generic presence and India's top pharma company.

The pharma major’s consolidated net profit increased 15.04% to Rs 2,903.38 crore on a 10.46% rise in revenue from operations to Rs 13,675.46 crore in Q3 FY25 over Q3 FY24

More News

(23-Apr-2025 17:40)
Tata Consumer Q4 PAT climbs 52% YoY to Rs 407 cr; recommends dividend of Rs 8.25/sh
(23-Apr-2025 17:28)
LTIMindtree Q4 PAT jumps 3% YoY to Rs 1,099 cr; declares dividend of Rs 45/sh
(23-Apr-2025 16:03)
Tips Music slides as Q4 PAT tumbles 31% QoQ to Rs 30 crore
(23-Apr-2025 15:14)
Shriram Properties jumps after acquiring 5-acre land parcel with GDV between Rs 200 -250 cr

More Company News View Company Information

Corporate News (10-Apr-2025 13:21)
Sun Pharma receives favourable ruling in preliminary injunction delaying launch of LEQSELVI™
Corporate News (07-Apr-2025 09:07)
Sun Pharmaceutical launches Fexuprazan tablets 40 mg in India
Hot Pursuit (07-Apr-2025 10:23)
Sun Pharma launches Fexuprazan tablets 40 mg in India
Hot Pursuit (18-Mar-2025 12:53)
Sun Pharma gains as arm acquires Antibe Therapeutics for $4.5 Million
Corporate News (18-Mar-2025 15:01)
Sun Pharma completes acquisition of Antibe Therapeutics Inc., Canada
Hot Pursuit (17-Mar-2025 13:00)
Sun Pharmaceuticals Industries Ltd soars 0.96%, gains for fifth straight session
Hot Pursuit (12-Mar-2025 13:05)
Sun Pharmaceuticals Industries Ltd rises for third straight session

Hot Pursuit News

Sun Pharma gains as arm acquires Antibe Therapeutics for $4.5 Million